Cellectis SA (CLLS)
1.87
-0.04
(-2.09%)
USD |
NASDAQ |
Nov 15, 16:00
1.86
-0.01
(-0.53%)
After-Hours: 20:00
Cellectis Shares Outstanding: 100.09M for Sept. 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
September 30, 2024 | 100.09M |
August 31, 2024 | 100.09M |
July 31, 2024 | 100.09M |
June 30, 2024 | 100.09M |
May 31, 2024 | 100.09M |
May 03, 2024 | 99.96M |
April 30, 2024 | 71.96M |
March 31, 2024 | 71.96M |
February 29, 2024 | 71.75M |
February 15, 2024 | 71.75M |
December 31, 2023 | 71.75M |
November 06, 2023 | 71.58M |
October 31, 2023 | 55.58M |
September 30, 2023 | 55.58M |
June 30, 2023 | 55.58M |
June 27, 2023 | 55.58M |
March 31, 2023 | 55.58M |
February 08, 2023 | 55.58M |
February 07, 2023 | 54.48M |
December 31, 2022 | 45.68M |
September 30, 2022 | 45.57M |
June 30, 2022 | 45.51M |
March 31, 2022 | 45.49M |
December 31, 2021 | 45.48M |
September 30, 2021 | 45.48M |
Date | Value |
---|---|
June 30, 2021 | 45.46M |
March 31, 2021 | 43.04M |
December 31, 2020 | 42.78M |
September 30, 2020 | 42.49M |
June 30, 2020 | 42.49M |
March 31, 2020 | 42.47M |
February 29, 2020 | 42.47M |
January 31, 2020 | 42.47M |
December 31, 2019 | 42.47M |
November 30, 2019 | 42.45M |
October 31, 2019 | 42.45M |
September 30, 2019 | 42.45M |
August 31, 2019 | 42.45M |
July 31, 2019 | 42.45M |
June 30, 2019 | 42.45M |
May 31, 2019 | 42.45M |
April 30, 2019 | 42.43M |
March 31, 2019 | 42.43M |
February 28, 2019 | 42.43M |
January 31, 2019 | 42.43M |
December 31, 2018 | 42.43M |
November 30, 2018 | 42.43M |
October 31, 2018 | 42.43M |
September 30, 2018 | 42.43M |
August 31, 2018 | 42.41M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
42.45M
Minimum
Nov 30 2019
100.09M
Maximum
Sep 30 2024
60.60M
Average
55.58M
Median
Mar 31 2023
Shares Outstanding Benchmarks
Edap TMS SA | 37.10M |
DBV Technologies SA | 96.20M |
Genfit SA | 49.91M |
Adaptimmune Therapeutics PLC | 255.88M |
Akari Therapeutics PLC | 11.95M |